CEA Industries Inc. (CEAD)

[Rick_Sanchez]

You hit the nail on the head, for sure.

At least in the United States, there is still so much legislature that needs to happen at the federal level regarding the legal scheduling of Cannabis and CBD. As each state legalizes recreational and medical use of Cannabis and CBD, they are all doing it their own way, within a framework they feel works. The federal government needs to come down and establish clear rules and procedures - and most importantly remove Cannabis from it's current Schedule 1 classification.

As it sits, Cannabis is on the same level as heroin and ecstasy. Crazy to think about right? That means the banking industry can't touch the money of companies that deal in Cannabis or they risk federal prosecution. That means payroll companies, like ADP, risk federal prosecution by processing a Cannabis firm's payroll. There are many financial hurdles and barriers like this that need to be removed for the industry itself to flourish.

All these things considered, I also agree with you that SRNA is undervalued even in it's current state. The floor here should be .10 - .15 and if their 2019 annual can show a net loss that is anything around $250K or less (which would mean the Q4 net income was positive again), then I think this could get even better.